Non ST-segment elevation myocardial infarction in patient with essential thrombocythemia

被引：6
作者：
Alioglu E. [1 ]
Tuzun N. [1 ]
Sahin F. [2 ]
Kosova B. [3 ]
Saygi S. [4 ]
Tengiz I. [1 ]
Turk U. [1 ]
Ozsan N. [5 ]
Ercan E. [6 ]
机构：
[1] Central Hospital, Department of Cardiology, Izmir
[2] Ege University School of Medicine, Department of Hematology, Izmir
[3] Ege University School of Medicine, Department of Medical Biology, Izmir
[4] Karsiyaka State Hospital, Department of Cardiology, Izmir
[5] Ege University School of Medicine, Department of Pathology, Izmire
[6] Canakkale Onsekiz Mart University, Faculty of Medicine, Department of Cardiology, Canakkale
来源：
Thrombosis Journal | / 7卷 / 1期
关键词：
Chronic Myeloid Leukemia; Right Coronary Artery; Polycythemia Vera; Essential Thrombocythemia; Myelofibrosis;
D O I：
10.1186/1477-9560-7-1
中图分类号：
学科分类号：
摘要：
A 68-year-old woman presented with acute chest pain and a greatly increased platelet count. Cardiac catheterization revealed subtotal occlusion and a thrombus-like filling defect in the right coronary artery. The patient was successfully treated with intravenous tirofiban. Essential thrombocythemia was diagnosed based on bone marrow findings, clinical presentation and laboratory analysis. The relationship between intracoronary thrombus and essential thrombocythemia is discussed. © 2009 Alioglu et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 26 条
  • [1] Spivak J.L., Polycythemia vera and other myeloproliferative diseases, Harrison's Principles of Internal Medicine, 1, pp. 683-684, (1998)
  • [2] Tefferi A., Vardiman J.W., Classification and diagnosis of myeloproliferative neoplasms: The 2008 WHO criteria and point-of-care diagnostic algorithms, Leukemia, 22, pp. 14-22, (2008)
  • [3] Cortelazzo S., Viero P., Finazzi G., D'Emilio A., Rodeghiero F., Barbui T., Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia, J Clin Oncol, 8, pp. 556-562, (1990)
  • [4] Mitus A.J., Schafer A.I., Thrombocytosis and thrombocythemia, Hematol Oncol Clin North Am, 4, pp. 157-177, (1990)
  • [5] Silverstein M.N., Primary or hemorrhagic thrombocythemia, Arch Intern Med, 122, pp. 18-22, (1968)
  • [6] Tirodo I., Fontcuberta J., Soria J.M., Rapid detection of the 46C → T polymorphism in the factor XII gene, a novel genetic risk factor for thrombosis, by melting peak analysis using fluorescence hybridization probes, Genet Test, 7, pp. 295-301, (2003)
  • [7] Zhou J., Chew M., Ravn H.B., Falk E., Plaque pathology and coronary thrombosis in the pathogenesis of acute coronary syndromes, Scand J Clin Lab Invest (Suppl), 230, pp. 3-11, (1999)
  • [8] Tun A., Khan I.A., Myocardial infarction with normal coronary arteries: The pathologic and clinical perspectives, Angiology, 52, pp. 299-304, (2001)
  • [9] Michiels J.J., Bernema Z., Van Bockstaele D., De Raeve H., Schroyens W., Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF), Pathol Biol (Paris), 55, 2, pp. 92-104, (2007)
  • [10] Sahin F., Saydam G., Essential thrombocythemia and cardiac disorders, J Card Res, 6, pp. 116-122, (2007)
123